Dipartimento di Fisiopatologia Cardiocircolatoria, Anestesiologia e Chirurgia, Istituto del Cuore Attilio Reale, Laboratory of Biotechnologies Applied to Cardiovascular Medicine, Sapienza Università di Roma, Viale del Policlinico, 155, Rome 00161, Italy.
Fundam Clin Pharmacol. 2012 Aug;26(4):445-53. doi: 10.1111/j.1472-8206.2011.00970.x. Epub 2011 Jul 21.
I(Ks) blockade might be a promising way to treat tachyarrhythmia because of the accumulation of activated potassium channels. However, I(Ks) blockade during ischemia/reperfusion has not been investigated. Thus, the electrophysiological effects of two I(Ks) blockers, chromanol 293B (10 μm) and HMR 1556 (1 μm), were assessed in an in vitro model of border zone between normal and ischemic/reperfused right ventricular myocardium from guinea-pigs, and classic electrophysiological parameters and the incidence of arrhythmias were studied. HMR 1556 and chromanol 293B exhibited slight conventional class III effects on action potential duration in the normal zone (NZ) (APD(90) : -2 ± 5%, not significant (NS); +6 ± 3%, NS; and +5 ± 1%, P < 0.05, respectively, in control, HMR 1556, and chromanol 293B groups) but failed to oppose its decrease after 30 min of simulated ischemic superfusion (APD(90) : -52 ± 5%, P < 0.01; -64 ± 5%, P < 0.01; and -61 ± 3%, P < 0.01, respectively, in control, HMR 1556, and chromanol 293B groups), leading to repolarization dispersion between normal and ischemic zones. Chromanol 293B and HMR 1556 prolonged APD(90) during reperfusion, respectively, by +11 ± 1%, P < 0.01 and +25 ± 4%, P < 0.01 in the NZ and by +13 ± 3%, NS and +31 ± 2%, P < 0.01 in the simulated ischemic zone. Both compounds exhibited neutral arrhythmogenic effects during ischemia or reperfusion. Thus, I(Ks) blockade was neutral on the occurrence of ventricular arrhythmias during ischemia and reperfusion in guinea-pig ventricular tissue.
I(Ks) 通道阻断可能是治疗心动过速性心律失常的一种很有前途的方法,因为它会导致激活的钾通道积聚。然而,缺血/再灌注期间的 I(Ks) 阻断尚未得到研究。因此,在豚鼠正常和缺血/再灌注右心室心肌交界区的体外模型中评估了两种 I(Ks) 阻断剂 chromanol 293B(10 μm)和 HMR 1556(1 μm)的电生理效应,并研究了经典电生理参数和心律失常的发生率。HMR 1556 和 chromanol 293B 在正常区(NZ)的动作电位时程(APD(90))上表现出轻微的传统 III 类效应(APD(90):-2 ± 5%,无统计学意义(NS);+6 ± 3%,NS;+5 ± 1%,P < 0.05,分别在对照、HMR 1556 和 chromanol 293B 组),但不能对抗缺血模拟再灌注 30 分钟后的降低(APD(90):-52 ± 5%,P < 0.01;-64 ± 5%,P < 0.01;-61 ± 3%,P < 0.01,分别在对照、HMR 1556 和 chromanol 293B 组),导致正常区和缺血区之间的复极离散。chromanol 293B 和 HMR 1556 分别在再灌注期间延长了 NZ 的 APD(90),分别为+11 ± 1%,P < 0.01 和+25 ± 4%,P < 0.01,在模拟缺血区分别为+13 ± 3%,NS 和+31 ± 2%,P < 0.01。这两种化合物在缺血或再灌注期间都表现出中性致心律失常作用。因此,在豚鼠心室组织中,I(Ks) 阻断对缺血和再灌注期间的室性心律失常的发生没有影响。